GLP-1 Analog
A GLP-1 receptor peptide formulated for intranasal delivery that mimics the body's natural incretin hormone to support appetite control, satiety signaling, and metabolic balance. This nasal formulation is designed for daily appetite regulation, not weekly pharmacologic dosing.
20 mg
>99%
160
Disclaimer: Dosing guides are provided as suggestions for prescribed use only in countries where the use of the respective peptides is legally permitted. These guides have not been approved by any regulatory authority and are not intended to constitute medical advice.
Protocol & Dosing
Use once or twice daily, ideally in the morning or before meals that typically trigger cravings. Nasal GLP-1 has a short duration of action, so consistent daily use provides the best results. Do NOT treat nasal GLP-1 as equivalent to injectable semaglutide — it is milder and designed for daily appetite support.
Key Benefits
Enhances satiety, reduces cravings, promotes balanced blood sugar levels, supports healthy weight management, and may improve overall metabolic wellness with consistent use.
Guidance
- Start with 1 spray, then wait 24–48 hours to assess appetite response
- Increase slowly only if needed
- Once your "sweet spot" is found, remain consistent at that dose until you feel an adjustment is necessary
- Do not exceed 4 sprays per day unless directed
- Best used daily or every other day, not sporadically
- Can be used alone or alongside lifestyle changes
Zenith Nano™ Spray System
Nasal delivery is facilitated with the Zenith Nano™ Spray System — a proprietary liquid ion delivery platform engineered for enhanced bioavailability, deep tissue penetration, and improved compound stability without compromising safety. Unlike carriers that rely on encapsulation, it enables direct solubilization and optimized partitioning of actives including peptides and coenzymes — no liposomes, no lipid nanoparticles, no emulsifier-dependent payloads. Built from amino acids and endogenous molecules for biocompatibility; scalable across routes that include intranasal sprays.
Compliance · Zenith Nano™ Peptides
cGMP manufacturing & cryopreservation
Manufactured through Pacific Manufacturing & Design LLC — GMP-certified under NSF/ANSI 455-2 and FDA-registered (Reg. No. 15492349536). Compliant with 21 CFR Parts 11, 111, and 117. Strict quality control, validated processes, and full traceability from raw material to final product.
Third-Party COA — Every Batch
Third-party COA for every batch, ensuring consistent quality and purity. Verified through LCMS and endotoxin testing, with full traceability from raw material to final product.